Global Intravitreal (IVT) Injectables Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Intravitreal (IVT) Injectables market size was valued at US$ 14210 million in 2023. With growing demand in downstream market, the Intravitreal (IVT) Injectables is forecast to a readjusted size of US$ 22140 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Intravitreal (IVT) Injectables market. Intravitreal (IVT) Injectables are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intravitreal (IVT) Injectables. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intravitreal (IVT) Injectables market.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Key Features:
The report on Intravitreal (IVT) Injectables market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Intravitreal (IVT) Injectables market. It may include historical data, market segmentation by Type (e.g., Anti-VEGF, Corticosteroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intravitreal (IVT) Injectables market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Intravitreal (IVT) Injectables market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Intravitreal (IVT) Injectables industry. This include advancements in Intravitreal (IVT) Injectables technology, Intravitreal (IVT) Injectables new entrants, Intravitreal (IVT) Injectables new investment, and other innovations that are shaping the future of Intravitreal (IVT) Injectables.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intravitreal (IVT) Injectables market. It includes factors influencing customer ' purchasing decisions, preferences for Intravitreal (IVT) Injectables product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intravitreal (IVT) Injectables market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intravitreal (IVT) Injectables market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intravitreal (IVT) Injectables market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intravitreal (IVT) Injectables industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intravitreal (IVT) Injectables market.
Market Segmentation:
Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Intravitreal (IVT) Injectables market?
What factors are driving Intravitreal (IVT) Injectables market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal (IVT) Injectables market opportunities vary by end market size?
How does Intravitreal (IVT) Injectables break out type, application?
According to our LPI (LP Information) latest study, the global Intravitreal (IVT) Injectables market size was valued at US$ 14210 million in 2023. With growing demand in downstream market, the Intravitreal (IVT) Injectables is forecast to a readjusted size of US$ 22140 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Intravitreal (IVT) Injectables market. Intravitreal (IVT) Injectables are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intravitreal (IVT) Injectables. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intravitreal (IVT) Injectables market.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Key Features:
The report on Intravitreal (IVT) Injectables market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Intravitreal (IVT) Injectables market. It may include historical data, market segmentation by Type (e.g., Anti-VEGF, Corticosteroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intravitreal (IVT) Injectables market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Intravitreal (IVT) Injectables market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Intravitreal (IVT) Injectables industry. This include advancements in Intravitreal (IVT) Injectables technology, Intravitreal (IVT) Injectables new entrants, Intravitreal (IVT) Injectables new investment, and other innovations that are shaping the future of Intravitreal (IVT) Injectables.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intravitreal (IVT) Injectables market. It includes factors influencing customer ' purchasing decisions, preferences for Intravitreal (IVT) Injectables product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intravitreal (IVT) Injectables market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intravitreal (IVT) Injectables market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intravitreal (IVT) Injectables market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intravitreal (IVT) Injectables industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intravitreal (IVT) Injectables market.
Market Segmentation:
Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Anti-VEGF
- Corticosteroids
- Antibiotics
- Antivirals
- Antifungals
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Regeneron Pharmaceuticals
- Bausch & Lomb
- Novartis
- Allergan
- Alimera Sciences
- ThromboGenics
- Bristol-Myers Squibb
What is the 10-year outlook for the global Intravitreal (IVT) Injectables market?
What factors are driving Intravitreal (IVT) Injectables market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal (IVT) Injectables market opportunities vary by end market size?
How does Intravitreal (IVT) Injectables break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal (IVT) Injectables Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal (IVT) Injectables by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal (IVT) Injectables by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal (IVT) Injectables Segment by Type
2.2.1 Anti-VEGF
2.2.2 Corticosteroids
2.2.3 Antibiotics
2.2.4 Antivirals
2.2.5 Antifungals
2.3 Intravitreal (IVT) Injectables Sales by Type
2.3.1 Global Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
2.3.2 Global Intravitreal (IVT) Injectables Revenue and Market Share by Type (2019-2024)
2.3.3 Global Intravitreal (IVT) Injectables Sale Price by Type (2019-2024)
2.4 Intravitreal (IVT) Injectables Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Mail Order Pharmacies
2.4.5 Others
2.5 Intravitreal (IVT) Injectables Sales by Application
2.5.1 Global Intravitreal (IVT) Injectables Sale Market Share by Application (2019-2024)
2.5.2 Global Intravitreal (IVT) Injectables Revenue and Market Share by Application (2019-2024)
2.5.3 Global Intravitreal (IVT) Injectables Sale Price by Application (2019-2024)
3 GLOBAL INTRAVITREAL (IVT) INJECTABLES BY COMPANY
3.1 Global Intravitreal (IVT) Injectables Breakdown Data by Company
3.1.1 Global Intravitreal (IVT) Injectables Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal (IVT) Injectables Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal (IVT) Injectables Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal (IVT) Injectables Revenue by Company (2019-2024)
3.2.2 Global Intravitreal (IVT) Injectables Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal (IVT) Injectables Sale Price by Company
3.4 Key Manufacturers Intravitreal (IVT) Injectables Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal (IVT) Injectables Product Location Distribution
3.4.2 Players Intravitreal (IVT) Injectables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL (IVT) INJECTABLES BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal (IVT) Injectables Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal (IVT) Injectables Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal (IVT) Injectables Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal (IVT) Injectables Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal (IVT) Injectables Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal (IVT) Injectables Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal (IVT) Injectables Sales Growth
4.4 APAC Intravitreal (IVT) Injectables Sales Growth
4.5 Europe Intravitreal (IVT) Injectables Sales Growth
4.6 Middle East & Africa Intravitreal (IVT) Injectables Sales Growth
5 AMERICAS
5.1 Americas Intravitreal (IVT) Injectables Sales by Country
5.1.1 Americas Intravitreal (IVT) Injectables Sales by Country (2019-2024)
5.1.2 Americas Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
5.2 Americas Intravitreal (IVT) Injectables Sales by Type
5.3 Americas Intravitreal (IVT) Injectables Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal (IVT) Injectables Sales by Region
6.1.1 APAC Intravitreal (IVT) Injectables Sales by Region (2019-2024)
6.1.2 APAC Intravitreal (IVT) Injectables Revenue by Region (2019-2024)
6.2 APAC Intravitreal (IVT) Injectables Sales by Type
6.3 APAC Intravitreal (IVT) Injectables Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal (IVT) Injectables by Country
7.1.1 Europe Intravitreal (IVT) Injectables Sales by Country (2019-2024)
7.1.2 Europe Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
7.2 Europe Intravitreal (IVT) Injectables Sales by Type
7.3 Europe Intravitreal (IVT) Injectables Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal (IVT) Injectables by Country
8.1.1 Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal (IVT) Injectables Sales by Type
8.3 Middle East & Africa Intravitreal (IVT) Injectables Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal (IVT) Injectables
10.3 Manufacturing Process Analysis of Intravitreal (IVT) Injectables
10.4 Industry Chain Structure of Intravitreal (IVT) Injectables
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal (IVT) Injectables Distributors
11.3 Intravitreal (IVT) Injectables Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL (IVT) INJECTABLES BY GEOGRAPHIC REGION
12.1 Global Intravitreal (IVT) Injectables Market Size Forecast by Region
12.1.1 Global Intravitreal (IVT) Injectables Forecast by Region (2025-2030)
12.1.2 Global Intravitreal (IVT) Injectables Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal (IVT) Injectables Forecast by Type
12.7 Global Intravitreal (IVT) Injectables Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Bausch & Lomb
13.2.1 Bausch & Lomb Company Information
13.2.2 Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bausch & Lomb Main Business Overview
13.2.5 Bausch & Lomb Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 Alimera Sciences
13.5.1 Alimera Sciences Company Information
13.5.2 Alimera Sciences Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Alimera Sciences Main Business Overview
13.5.5 Alimera Sciences Latest Developments
13.6 ThromboGenics
13.6.1 ThromboGenics Company Information
13.6.2 ThromboGenics Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ThromboGenics Main Business Overview
13.6.5 ThromboGenics Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal (IVT) Injectables Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal (IVT) Injectables by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal (IVT) Injectables by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal (IVT) Injectables Segment by Type
2.2.1 Anti-VEGF
2.2.2 Corticosteroids
2.2.3 Antibiotics
2.2.4 Antivirals
2.2.5 Antifungals
2.3 Intravitreal (IVT) Injectables Sales by Type
2.3.1 Global Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
2.3.2 Global Intravitreal (IVT) Injectables Revenue and Market Share by Type (2019-2024)
2.3.3 Global Intravitreal (IVT) Injectables Sale Price by Type (2019-2024)
2.4 Intravitreal (IVT) Injectables Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Mail Order Pharmacies
2.4.5 Others
2.5 Intravitreal (IVT) Injectables Sales by Application
2.5.1 Global Intravitreal (IVT) Injectables Sale Market Share by Application (2019-2024)
2.5.2 Global Intravitreal (IVT) Injectables Revenue and Market Share by Application (2019-2024)
2.5.3 Global Intravitreal (IVT) Injectables Sale Price by Application (2019-2024)
3 GLOBAL INTRAVITREAL (IVT) INJECTABLES BY COMPANY
3.1 Global Intravitreal (IVT) Injectables Breakdown Data by Company
3.1.1 Global Intravitreal (IVT) Injectables Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal (IVT) Injectables Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal (IVT) Injectables Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal (IVT) Injectables Revenue by Company (2019-2024)
3.2.2 Global Intravitreal (IVT) Injectables Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal (IVT) Injectables Sale Price by Company
3.4 Key Manufacturers Intravitreal (IVT) Injectables Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal (IVT) Injectables Product Location Distribution
3.4.2 Players Intravitreal (IVT) Injectables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL (IVT) INJECTABLES BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal (IVT) Injectables Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal (IVT) Injectables Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal (IVT) Injectables Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal (IVT) Injectables Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal (IVT) Injectables Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal (IVT) Injectables Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal (IVT) Injectables Sales Growth
4.4 APAC Intravitreal (IVT) Injectables Sales Growth
4.5 Europe Intravitreal (IVT) Injectables Sales Growth
4.6 Middle East & Africa Intravitreal (IVT) Injectables Sales Growth
5 AMERICAS
5.1 Americas Intravitreal (IVT) Injectables Sales by Country
5.1.1 Americas Intravitreal (IVT) Injectables Sales by Country (2019-2024)
5.1.2 Americas Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
5.2 Americas Intravitreal (IVT) Injectables Sales by Type
5.3 Americas Intravitreal (IVT) Injectables Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal (IVT) Injectables Sales by Region
6.1.1 APAC Intravitreal (IVT) Injectables Sales by Region (2019-2024)
6.1.2 APAC Intravitreal (IVT) Injectables Revenue by Region (2019-2024)
6.2 APAC Intravitreal (IVT) Injectables Sales by Type
6.3 APAC Intravitreal (IVT) Injectables Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal (IVT) Injectables by Country
7.1.1 Europe Intravitreal (IVT) Injectables Sales by Country (2019-2024)
7.1.2 Europe Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
7.2 Europe Intravitreal (IVT) Injectables Sales by Type
7.3 Europe Intravitreal (IVT) Injectables Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal (IVT) Injectables by Country
8.1.1 Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal (IVT) Injectables Sales by Type
8.3 Middle East & Africa Intravitreal (IVT) Injectables Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal (IVT) Injectables
10.3 Manufacturing Process Analysis of Intravitreal (IVT) Injectables
10.4 Industry Chain Structure of Intravitreal (IVT) Injectables
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal (IVT) Injectables Distributors
11.3 Intravitreal (IVT) Injectables Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL (IVT) INJECTABLES BY GEOGRAPHIC REGION
12.1 Global Intravitreal (IVT) Injectables Market Size Forecast by Region
12.1.1 Global Intravitreal (IVT) Injectables Forecast by Region (2025-2030)
12.1.2 Global Intravitreal (IVT) Injectables Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal (IVT) Injectables Forecast by Type
12.7 Global Intravitreal (IVT) Injectables Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Bausch & Lomb
13.2.1 Bausch & Lomb Company Information
13.2.2 Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bausch & Lomb Main Business Overview
13.2.5 Bausch & Lomb Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 Alimera Sciences
13.5.1 Alimera Sciences Company Information
13.5.2 Alimera Sciences Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Alimera Sciences Main Business Overview
13.5.5 Alimera Sciences Latest Developments
13.6 ThromboGenics
13.6.1 ThromboGenics Company Information
13.6.2 ThromboGenics Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ThromboGenics Main Business Overview
13.6.5 ThromboGenics Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravitreal (IVT) Injectables Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal (IVT) Injectables Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Antibiotics
Table 6. Major Players of Antivirals
Table 7. Major Players of Antifungals
Table 8. Global Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 9. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Table 10. Global Intravitreal (IVT) Injectables Revenue by Type (2019-2024) & ($ million)
Table 11. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2019-2024)
Table 12. Global Intravitreal (IVT) Injectables Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 14. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Table 15. Global Intravitreal (IVT) Injectables Revenue by Application (2019-2024)
Table 16. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2019-2024)
Table 17. Global Intravitreal (IVT) Injectables Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Intravitreal (IVT) Injectables Sales by Company (2019-2024) & (K Units)
Table 19. Global Intravitreal (IVT) Injectables Sales Market Share by Company (2019-2024)
Table 20. Global Intravitreal (IVT) Injectables Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Intravitreal (IVT) Injectables Revenue Market Share by Company (2019-2024)
Table 22. Global Intravitreal (IVT) Injectables Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Intravitreal (IVT) Injectables Producing Area Distribution and Sales Area
Table 24. Players Intravitreal (IVT) Injectables Products Offered
Table 25. Intravitreal (IVT) Injectables Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Intravitreal (IVT) Injectables Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Intravitreal (IVT) Injectables Sales Market Share Geographic Region (2019-2024)
Table 30. Global Intravitreal (IVT) Injectables Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Intravitreal (IVT) Injectables Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Intravitreal (IVT) Injectables Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Intravitreal (IVT) Injectables Sales Market Share by Country/Region (2019-2024)
Table 34. Global Intravitreal (IVT) Injectables Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Intravitreal (IVT) Injectables Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 37. Americas Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 38. Americas Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 40. Americas Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 41. Americas Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 42. APAC Intravitreal (IVT) Injectables Sales by Region (2019-2024) & (K Units)
Table 43. APAC Intravitreal (IVT) Injectables Sales Market Share by Region (2019-2024)
Table 44. APAC Intravitreal (IVT) Injectables Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Intravitreal (IVT) Injectables Revenue Market Share by Region (2019-2024)
Table 46. APAC Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 47. APAC Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 48. Europe Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 49. Europe Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 50. Europe Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 52. Europe Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 53. Europe Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Intravitreal (IVT) Injectables
Table 61. Key Market Challenges & Risks of Intravitreal (IVT) Injectables
Table 62. Key Industry Trends of Intravitreal (IVT) Injectables
Table 63. Intravitreal (IVT) Injectables Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Intravitreal (IVT) Injectables Distributors List
Table 66. Intravitreal (IVT) Injectables Customer List
Table 67. Global Intravitreal (IVT) Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Intravitreal (IVT) Injectables Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Intravitreal (IVT) Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Intravitreal (IVT) Injectables Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Intravitreal (IVT) Injectables Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Intravitreal (IVT) Injectables Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Intravitreal (IVT) Injectables Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Intravitreal (IVT) Injectables Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Regeneron Pharmaceuticals Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 82. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 83. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Regeneron Pharmaceuticals Main Business
Table 85. Regeneron Pharmaceuticals Latest Developments
Table 86. Bausch & Lomb Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 87. Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 88. Bausch & Lomb Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bausch & Lomb Main Business
Table 90. Bausch & Lomb Latest Developments
Table 91. Novartis Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 93. Novartis Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Allergan Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 97. Allergan Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 98. Allergan Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Allergan Main Business
Table 100. Allergan Latest Developments
Table 101. Alimera Sciences Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 102. Alimera Sciences Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 103. Alimera Sciences Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Alimera Sciences Main Business
Table 105. Alimera Sciences Latest Developments
Table 106. ThromboGenics Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 107. ThromboGenics Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 108. ThromboGenics Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ThromboGenics Main Business
Table 110. ThromboGenics Latest Developments
Table 111. Bristol-Myers Squibb Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 112. Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 113. Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bristol-Myers Squibb Main Business
Table 115. Bristol-Myers Squibb Latest Developments
Table 1. Intravitreal (IVT) Injectables Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal (IVT) Injectables Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Antibiotics
Table 6. Major Players of Antivirals
Table 7. Major Players of Antifungals
Table 8. Global Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 9. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Table 10. Global Intravitreal (IVT) Injectables Revenue by Type (2019-2024) & ($ million)
Table 11. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2019-2024)
Table 12. Global Intravitreal (IVT) Injectables Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 14. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Table 15. Global Intravitreal (IVT) Injectables Revenue by Application (2019-2024)
Table 16. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2019-2024)
Table 17. Global Intravitreal (IVT) Injectables Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Intravitreal (IVT) Injectables Sales by Company (2019-2024) & (K Units)
Table 19. Global Intravitreal (IVT) Injectables Sales Market Share by Company (2019-2024)
Table 20. Global Intravitreal (IVT) Injectables Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Intravitreal (IVT) Injectables Revenue Market Share by Company (2019-2024)
Table 22. Global Intravitreal (IVT) Injectables Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Intravitreal (IVT) Injectables Producing Area Distribution and Sales Area
Table 24. Players Intravitreal (IVT) Injectables Products Offered
Table 25. Intravitreal (IVT) Injectables Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Intravitreal (IVT) Injectables Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Intravitreal (IVT) Injectables Sales Market Share Geographic Region (2019-2024)
Table 30. Global Intravitreal (IVT) Injectables Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Intravitreal (IVT) Injectables Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Intravitreal (IVT) Injectables Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Intravitreal (IVT) Injectables Sales Market Share by Country/Region (2019-2024)
Table 34. Global Intravitreal (IVT) Injectables Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Intravitreal (IVT) Injectables Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 37. Americas Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 38. Americas Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 40. Americas Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 41. Americas Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 42. APAC Intravitreal (IVT) Injectables Sales by Region (2019-2024) & (K Units)
Table 43. APAC Intravitreal (IVT) Injectables Sales Market Share by Region (2019-2024)
Table 44. APAC Intravitreal (IVT) Injectables Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Intravitreal (IVT) Injectables Revenue Market Share by Region (2019-2024)
Table 46. APAC Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 47. APAC Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 48. Europe Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 49. Europe Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 50. Europe Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 52. Europe Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 53. Europe Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Intravitreal (IVT) Injectables Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Intravitreal (IVT) Injectables
Table 61. Key Market Challenges & Risks of Intravitreal (IVT) Injectables
Table 62. Key Industry Trends of Intravitreal (IVT) Injectables
Table 63. Intravitreal (IVT) Injectables Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Intravitreal (IVT) Injectables Distributors List
Table 66. Intravitreal (IVT) Injectables Customer List
Table 67. Global Intravitreal (IVT) Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Intravitreal (IVT) Injectables Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Intravitreal (IVT) Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Intravitreal (IVT) Injectables Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Intravitreal (IVT) Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Intravitreal (IVT) Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Intravitreal (IVT) Injectables Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Intravitreal (IVT) Injectables Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Intravitreal (IVT) Injectables Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Intravitreal (IVT) Injectables Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Regeneron Pharmaceuticals Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 82. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 83. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Regeneron Pharmaceuticals Main Business
Table 85. Regeneron Pharmaceuticals Latest Developments
Table 86. Bausch & Lomb Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 87. Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 88. Bausch & Lomb Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bausch & Lomb Main Business
Table 90. Bausch & Lomb Latest Developments
Table 91. Novartis Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 93. Novartis Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Allergan Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 97. Allergan Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 98. Allergan Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Allergan Main Business
Table 100. Allergan Latest Developments
Table 101. Alimera Sciences Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 102. Alimera Sciences Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 103. Alimera Sciences Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Alimera Sciences Main Business
Table 105. Alimera Sciences Latest Developments
Table 106. ThromboGenics Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 107. ThromboGenics Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 108. ThromboGenics Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ThromboGenics Main Business
Table 110. ThromboGenics Latest Developments
Table 111. Bristol-Myers Squibb Basic Information, Intravitreal (IVT) Injectables Manufacturing Base, Sales Area and Its Competitors
Table 112. Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolios and Specifications
Table 113. Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bristol-Myers Squibb Main Business
Table 115. Bristol-Myers Squibb Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravitreal (IVT) Injectables
Figure 2. Intravitreal (IVT) Injectables Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal (IVT) Injectables Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal (IVT) Injectables Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal (IVT) Injectables Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Antivirals
Figure 13. Product Picture of Antifungals
Figure 14. Global Intravitreal (IVT) Injectables Sales Market Share by Type in 2023
Figure 15. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2019-2024)
Figure 16. Intravitreal (IVT) Injectables Consumed in Hospital Pharmacies
Figure 17. Global Intravitreal (IVT) Injectables Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Intravitreal (IVT) Injectables Consumed in Retail Pharmacies
Figure 19. Global Intravitreal (IVT) Injectables Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. Intravitreal (IVT) Injectables Consumed in Drug Stores
Figure 21. Global Intravitreal (IVT) Injectables Market: Drug Stores (2019-2024) & (K Units)
Figure 22. Intravitreal (IVT) Injectables Consumed in Mail Order Pharmacies
Figure 23. Global Intravitreal (IVT) Injectables Market: Mail Order Pharmacies (2019-2024) & (K Units)
Figure 24. Intravitreal (IVT) Injectables Consumed in Others
Figure 25. Global Intravitreal (IVT) Injectables Market: Others (2019-2024) & (K Units)
Figure 26. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2023)
Figure 27. Global Intravitreal (IVT) Injectables Revenue Market Share by Application in 2023
Figure 28. Intravitreal (IVT) Injectables Sales Market by Company in 2023 (K Units)
Figure 29. Global Intravitreal (IVT) Injectables Sales Market Share by Company in 2023
Figure 30. Intravitreal (IVT) Injectables Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Intravitreal (IVT) Injectables Revenue Market Share by Company in 2023
Figure 32. Global Intravitreal (IVT) Injectables Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Intravitreal (IVT) Injectables Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 35. Americas Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 36. APAC Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 37. APAC Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 38. Europe Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 39. Europe Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 42. Americas Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 43. Americas Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 44. Americas Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 45. Americas Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 46. United States Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Intravitreal (IVT) Injectables Sales Market Share by Region in 2023
Figure 51. APAC Intravitreal (IVT) Injectables Revenue Market Share by Regions in 2023
Figure 52. APAC Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 53. APAC Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 54. China Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 62. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 63. Europe Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 64. Europe Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 65. Germany Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 74. Egypt Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Intravitreal (IVT) Injectables in 2023
Figure 80. Manufacturing Process Analysis of Intravitreal (IVT) Injectables
Figure 81. Industry Chain Structure of Intravitreal (IVT) Injectables
Figure 82. Channels of Distribution
Figure 83. Global Intravitreal (IVT) Injectables Sales Market Forecast by Region (2025-2030)
Figure 84. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Intravitreal (IVT) Injectables Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Intravitreal (IVT) Injectables Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Intravitreal (IVT) Injectables
Figure 2. Intravitreal (IVT) Injectables Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal (IVT) Injectables Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal (IVT) Injectables Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal (IVT) Injectables Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Antivirals
Figure 13. Product Picture of Antifungals
Figure 14. Global Intravitreal (IVT) Injectables Sales Market Share by Type in 2023
Figure 15. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2019-2024)
Figure 16. Intravitreal (IVT) Injectables Consumed in Hospital Pharmacies
Figure 17. Global Intravitreal (IVT) Injectables Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Intravitreal (IVT) Injectables Consumed in Retail Pharmacies
Figure 19. Global Intravitreal (IVT) Injectables Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. Intravitreal (IVT) Injectables Consumed in Drug Stores
Figure 21. Global Intravitreal (IVT) Injectables Market: Drug Stores (2019-2024) & (K Units)
Figure 22. Intravitreal (IVT) Injectables Consumed in Mail Order Pharmacies
Figure 23. Global Intravitreal (IVT) Injectables Market: Mail Order Pharmacies (2019-2024) & (K Units)
Figure 24. Intravitreal (IVT) Injectables Consumed in Others
Figure 25. Global Intravitreal (IVT) Injectables Market: Others (2019-2024) & (K Units)
Figure 26. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2023)
Figure 27. Global Intravitreal (IVT) Injectables Revenue Market Share by Application in 2023
Figure 28. Intravitreal (IVT) Injectables Sales Market by Company in 2023 (K Units)
Figure 29. Global Intravitreal (IVT) Injectables Sales Market Share by Company in 2023
Figure 30. Intravitreal (IVT) Injectables Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Intravitreal (IVT) Injectables Revenue Market Share by Company in 2023
Figure 32. Global Intravitreal (IVT) Injectables Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Intravitreal (IVT) Injectables Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 35. Americas Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 36. APAC Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 37. APAC Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 38. Europe Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 39. Europe Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Intravitreal (IVT) Injectables Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Intravitreal (IVT) Injectables Revenue 2019-2024 ($ Millions)
Figure 42. Americas Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 43. Americas Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 44. Americas Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 45. Americas Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 46. United States Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Intravitreal (IVT) Injectables Sales Market Share by Region in 2023
Figure 51. APAC Intravitreal (IVT) Injectables Revenue Market Share by Regions in 2023
Figure 52. APAC Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 53. APAC Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 54. China Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 62. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 63. Europe Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 64. Europe Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 65. Germany Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2024)
Figure 74. Egypt Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Intravitreal (IVT) Injectables Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Intravitreal (IVT) Injectables in 2023
Figure 80. Manufacturing Process Analysis of Intravitreal (IVT) Injectables
Figure 81. Industry Chain Structure of Intravitreal (IVT) Injectables
Figure 82. Channels of Distribution
Figure 83. Global Intravitreal (IVT) Injectables Sales Market Forecast by Region (2025-2030)
Figure 84. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Intravitreal (IVT) Injectables Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Intravitreal (IVT) Injectables Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Intravitreal (IVT) Injectables Revenue Market Share Forecast by Application (2025-2030)
